Natco Pharma shares gained 12% to Rs 918 in the current session against the previous close of Rs 822.10.

Healthcare industry stocks are traditionally good hedges against technology and other growth stocks, because they tend to ...

And there's more than one way to monetize this technology.

Torrent Pharma share price jumped as much as 6% in the morning trade on Monday, February 16, to hit a record high of ...

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income and long-term wealth creation can benefit from adding dividend-paying ...

This pharma player offers you safety and growth. The company is a leader in a market that may approach $100 billion by the end of the decade. When you think of the path to millions, you may think of ...

Syndax Pharmaceuticals is now a commercial-stage biopharma with two FDA-approved drugs: Revuforj and Niktimvo. Syndax's Revuforj leads in efficacy for AML, with rapid market penetration and a ...

The directory offers vital insights into 1,000 top global pharmaceutical and biotech companies, featuring key management, business activities, and more. It aids market research, strategic planning, ...

Investing.com -- OKYO Pharma Limited (NASDAQ:OKYO) stock fell 24% in Friday’s premarket trading after the company announced a $20 million public offering of its ordinary shares.